Dot1L-IN-9
Dot1L-IN-9 (Compound 12) is a DOT1L inhibitor (IC50: 125 nM) . Dot1L-IN-9 reduces H3K79 dimethylation. Dot1L-IN-9 can be used for anti-leukemia research[1].
Product Specifications
UNSPSC
12352005
Target
Histone Methyltransferase
Type
Reference compound
Related Pathways
Epigenetics
Field of Research
Cancer
Assay Protocol
https://www.medchemexpress.com/dot1l-in-9.html
Smiles
NC1=C2N=CN(C2=NC=N1)[C@@H]3O[C@H](CN4CCC(CCC5=NC6=CC(C(C)(C)C)=CC=C6N5)CC4)[C@@H](O)[C@H]3O
Molecular Formula
C28H38N8O3
Molecular Weight
534.65
References & Citations
[1]Sethy B, et al. Design, synthesis, and biological evaluation of adenosine derivatives targeting DOT1L and HAT as anti-leukemia agents. Bioorg Chem. 2024 Sep 6;153:107771.
Shipping Conditions
Room temperature
Scientific Category
Reference compound1
Clinical Information
No Development Reported
Isoform
DOT1L
Frequently Asked Questions
More Discoveries
Explore Other Products
Browse additional items from our catalog
LV676249 1.0 µg DNA
FADS2 Lentiviral Vector (Rat) (CMV) (pLenti-GIII-CMV)
Sign In for Pricing
View Details 